Kymera Therapeutics, Inc. · NASDAQ:KYMR
Wellington Management Group LLP reported a 8.20% stake in Kymera Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 10, 2025
Wellington Management Group LLP reported a 8.20% stake in Kymera Therapeutics, Inc., 5,307,326 shares, as a passive investor on Dec 31, 2024. Filed Feb 10, 2025 (Schedule 13G/A).
- Stake
- 8.20%
- Shares
- 5,307,326
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Wellington Management Group LLP | 8.20% | 5,307,326 |
| Wellington Group Holdings LLP | 8.20% | 5,307,326 |
| Wellington Investment Advisors Holdings LLP | 8.20% | 5,307,326 |
| Wellington Management Company LLP | 8.00% | 5,307,326 |
Source
Related
- Kymera Therapeutics, Inc.
- Wellington Management Group LLP
- Kymera Therapeutics, Inc. shareholders
- Schedule 13G/A · Wellington Management Group LLP · May 15, 2026
- Schedule 13G/A · Wellington Management Group LLP · Feb 10, 2026
- Schedule 13G/A · Wellington Management Group LLP · Aug 12, 2025
- Schedule 13G/A · Wellington Management Group LLP · May 12, 2025
- Form 4 · Mainolfi Nello · Oct 1, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Sep 8, 2026
- Form 4 · Adams Brian · Sep 4, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · Atlas Venture Fund X, L.P. · Aug 13, 2026